CYR-064 Controlled Trial
Clinical
Flavor Loss
Trial
Condition: Hyposmia
A Randomized, Double-Blinded, Placebo-Controlled Trial to Determine The Safety and Efficacy of CYR-064
The purpose of this study is to determine the safety and effectiveness of CYR-064 in a randomized, double-blinded, placebo-controlled trial to determine the safety and efficacy of CYR064.
The study will take approximately 32 weeks which will include a 4-week screening period to evaluate if participants are right for the Study, followed by a 24-week Treatment Period, and a 1 week follow up after participants have completed the Study. About 150 subjects will participate in this study in about 25 research sites in the United States.
Study Start Date
9.26.23
Primary Completion
9.24.24
Study Completon Date
1.30.25
A Groundbreaking Clinical Trial
Explore the potential benefits of participating in our Clinical Flavor Loss Trial with CYR-064, a groundbreaking study that aims to redefine the treatment landscape for flavor loss.
This randomized, double-blinded, placebo-controlled trial is designed to assess the safety and efficacy of CYR-064 in treating taste dysfunction. Participants have the unique opportunity to access cutting-edge treatments and contribute to medical research that could lead to new solutions for those suffering from flavor loss. Our dedicated team ensures thorough monitoring and support throughout the study, ensuring the highest standards of care.
Are You Interested in Contributing to a Major Advancement in Flavor Loss Treatment?
Join our Clinical Flavor Loss Trial of CYR-064 while positions are still available! This is your chance to be part of a leading-edge study that not only offers potential personal health benefits but also contributes to broader medical advancements. Don’t miss out on this opportunity to participate in a pivotal research effort concluding in January 2025.
Apply now to secure your place in this important trial, and take an active role in shaping the future of taste dysfunction treatment.